leisure time -WSS

leisure time

author：focus 2025-09-06 03:32:22 - browse：366

Adam's take main illustration — Molly Ferguson/STAT

For two days starting on Sunday, Moonlake Immunotherapeutics happily crunched numbers and shared results from a mid-stage clinical trial that depicted its experimental antibody in the most flattering terms possible.

The drug, called sonelokimab, was “changing the game” for the treatment of a debilitating skin condition called hidradenitis suppurativa, or HS, said Moonlake CEO Jorge Santos da Silva, on a call for investors and analysts. The drug’s benefit for patients placed it “at the top of the heap,” he added.

For other, equally important data from the same study that did not fit Moonlake’s home-run narrative, the company took a DIY approach. Curious about how sonelokimab performed against a treatment that’s already approved for HS? Pull out a calculator and do the math yourself. How badly did a higher dose of the drug underperform a lower dose? Take a guess.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： Adele warns fans about throwing things at performers onstage

entertainment

WSS

Xenotransplantation trials will require adjusting expectations, experts say

Myanmar's Supreme Court hears arguments in 2 appeals by ousted leader Aung San Suu Kyi

Biogen nominates mother of director’s child to replace him on board

Over 1,300 arrested in France in 4th night of protests over fatal police shooting of teen Nahel M.

FDA approves first new drug developed for postpartum depression

Dramatic video released of Russian fighter jets 'harassing' US drones over Syria

focus

leisure time

explore

How to save PrEP access — and even expand it

A public health expert passes on football's full body collisions for youths

Medicare details structure of new drug price negotiation program

2 million sign

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Canadian wildfire dangers should prompt more proactive mitigation from government: Experts

The high cost of giving birth even with insurance

1 in 4 Americans hadn't contracted COVID by the end of 2022, CDC estimates

Dobbs anniversary: the lost opportunity of abortion as health care

Biden administration plans revamp of organ transplant system

hotspot

Science's Marcia McNutt, trailblazer for women, encounters sexism scandal

'Insanity': 4th of July mass shootings across US kill 13, injure more than 80

Ph.D. graduate surprised with gift registry: 'You deserve to be celebrated'

Dramatic video released of Russian fighter jets 'harassing' US drones over Syria

Myanmar's Supreme Court hears arguments in 2 appeals by ousted leader Aung San Suu Kyi

Altering the blood type of lungs raises potential for universal organs for transplants

focus

entertainment

leisure time

focus